You are here

Home

Clinical Trials: Musculoskeletal Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, April 25, 2022 - 12:00
A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis
Condition:   Osteoarthritis, Knee
Intervention:   Biological: XSTEM-OA
Sponsors:   Xindu Pty Ltd;   Xintela AB
Not yet recruiting
Posted: Monday, March 21, 2022 - 12:00
Mesenchymal Stem Cell Therapy for Knee Osteoarthritis
Condition:   Osteoarthritis, Knee
Interventions:   Biological: Bone Marrow Derived MSCs;   Drug: Corticosteroid;   Device: Bone Marrow Aspirate
Sponsor:   Next Generation Regenerative Medicine LLC
Not yet recruiting
Posted: Wednesday, March 2, 2022 - 12:00
Clinical Efficacy of Exosome in Degenerative Meniscal Injury
Conditions:   Knee; Injury, Meniscus (Lateral) (Medial);   Meniscus Tear;   Meniscus Lesion;   Meniscus; Degeneration;   Meniscus; Laceration;   Meniscus Injury, Tibial;   Knee Injuries;   Knee Pain Swelling;   Arthralgia
Interventions:   Drug: SF-MSC-EX;   Drug: SF-MSC
Sponsors:   Eskisehir Osmangazi University;   The Scientific and Technological Research Council of Turkey
Not yet recruiting
Posted: Thursday, January 27, 2022 - 12:00
Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
Condition:   Muscle Atrophy
Intervention:   Drug: IMM01-STEM
Sponsor:   Immunis, Inc.
Not yet recruiting
Posted: Monday, January 17, 2022 - 12:00
Autologous Bone Marrow Aspirate Concentrate Injection for the Treatment of Early Osteoarthritis: a Randomized Controlled Trial, Baghdad 2022
Condition:   Treatment Complication
Intervention:   Procedure: autologous bone marrow aspirate concentrate by centrifugation
Sponsor:   zaid husein ali
Not yet recruiting
Posted: Friday, January 7, 2022 - 12:00
Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis
Condition:   Knee Osteoarthritis
Interventions:   Biological: SMUP-IA-01(low dose);   Biological: SMUP-IA-01(mid dose);   Drug: Active Control Group Sodium chloride
Sponsor:   Medipost Co Ltd.
Not yet recruiting
Posted: Thursday, December 16, 2021 - 12:00
Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis
Condition:   Knee Osteoarthritis
Intervention:   Biological: Human umbilical cord mesenchymal stem cells
Sponsor:   Southwest Hospital, China
Not yet recruiting
Posted: Thursday, December 9, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Osteoporosis
Condition:   Osteoporosis
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Tuesday, December 7, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for OA
Conditions:   Osteoarthritis;   Spinal Arthritis
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Friday, November 19, 2021 - 12:00
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (HOPE-3)
Conditions:   Muscular Dystrophies;   Muscular Dystrophy, Duchenne;   Muscular Disorders, Atrophic;   Muscular Diseases;   Neuromuscular Diseases;   Genetic Diseases, X-Linked;   Genetic Diseases, Inborn;   Nervous System Diseases
Interventions:   Biological: CAP-1002;   Drug: Placebo
Sponsor:   Capricor Inc.
Not yet recruiting

Pages